Despite representing distinct tumour types, there has been limited success in identifying gene expression profiles related to BRCA1 and BRCA2 pathogenic variants in either tumour [3, 21–24] or normal tissue [25–28]. The gene discussed is BRCA2; the disease is neoplasm.